Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapy ; volume:22 ; number:1 ; day:28 ; month:7 ; year:2022 ; pages:1-11 ; date:12.2022
BMC ophthalmology ; 22, Heft 1 (28.7.2022), 1-11, 12.2022
- Creator
-
Yap, Aaron
Wang, Nancy
Squirrell, David
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-022-02551-3
- URN
-
urn:nbn:de:101:1-2022102310102064291156
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-15T07:20:20+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yap, Aaron
- Wang, Nancy
- Squirrell, David
- SpringerLink (Online service)
Other Objects (12)
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients
Choroidal nevus and polypoidal vasculopathy: case series
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Quantitative analysis of choroidal vasculature in polypoidal choroidal vasculopathy using ultra-widefield indocyanine green angiography
Exploring the Ability of Novel Choroidal Biomarkers in Predicting Treatment Outcomes of Polypoidal Choroidal Vasculopathy
Systemic Risk Factors for Vitreous Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients
Choroidal nevus and polypoidal vasculopathy: case series
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Quantitative analysis of choroidal vasculature in polypoidal choroidal vasculopathy using ultra-widefield indocyanine green angiography
Exploring the Ability of Novel Choroidal Biomarkers in Predicting Treatment Outcomes of Polypoidal Choroidal Vasculopathy
Systemic Risk Factors for Vitreous Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients
Choroidal nevus and polypoidal vasculopathy: case series
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Quantitative analysis of choroidal vasculature in polypoidal choroidal vasculopathy using ultra-widefield indocyanine green angiography
Exploring the Ability of Novel Choroidal Biomarkers in Predicting Treatment Outcomes of Polypoidal Choroidal Vasculopathy